• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项系统评价和荟萃分析,以检验诸如黏膜基底浆细胞增多症和嗜酸性粒细胞增多症等组织学参数在区分炎症性肠病和非炎症性肠病型结肠炎中的效用。

A Systematic Review and Metaanalysis to Examine the Utility of Histological Parameters Such as Mucosal Basal Plasmacytosis and Eosinophilia for Distinguishing Inflammatory Bowel Disease and Non-IBD-Type Colitis.

作者信息

Bhowmik Shubham, Mehra Lalita, Ghosh Tamoghna, Akhtar Sagir, Tiwari Ashok, Dutta Rimlee, Kedia Saurav, Yadav Rajni, Makharia Govind K, Ahuja Vineet, Das Prasenjit

机构信息

Department of Pathology, All India Institute of Medical Sciences, New Delhi, DL, India.

Department of Gastroenterology All India Institute of Medical Sciences, New Delhi, DL, India.

出版信息

Int J Surg Pathol. 2025 May;33(3):516-527. doi: 10.1177/10668969241271352. Epub 2024 Sep 19.

DOI:10.1177/10668969241271352
PMID:39300818
Abstract

Basic differentiation between an inflammatory bowel disease (IBD)-type colitis and a non-IBD type of colitis is the essential histological pre-requisite before further subclassifications are made. The combination of mucosal prominent eosinophilic cell infiltrate along with basal plasmacytosis is supposed to be a useful histological feature that can differentiate between IBD-type and non-IBD-type colitis. Hence, this systematic review and metaanalysis aimed to assess the reliability of mucosal basal plasmacytosis and eosinophilia for histological differentiation of IBD-type versus non-IBD-type colitis. We searched the PROSPERO, PubMed, Embase, and Scopus from January 1, 2000 to July 30, 2022 for all types of studies (prospective, cross-sectional, or retrospective studies) having histological features (including mucosal basal plasmacytosis, eosinophilia, and neutrophilic infiltration) in IBD and/or non-IBD colitis cases. Two reviewers extracted data, which were aggregated using random-effects models. The 59 selected articles were evaluated for the predecided parameters. Both basal plasmacytosis and lamina propria plasmacytosis did not show any significant correlation between IBD-type and non-IBD-type colitis. The proportions for basal plasmacytosis with 95% CI were 0.50 (0.19-0.82) in IBD-type colitis and 0.46 (0.40-0.52) in non-IBD-type colitis, with a value of .79. The proportion of lamina propria plasmacytosis with 95% CI was 0.67 (0.42-0.92) in IBD and 0.60 (0.35-0.85) in non-IBD-type colitis, with a value being .7. This systematic review documented the dearth of published data on key histological features such as basal plasmacytosis and mucosal eosinophilia which are believed to differentiate between IBD-type and non-IBD-type colitis.

摘要

在进行进一步的亚分类之前,区分炎症性肠病(IBD)型结肠炎和非IBD型结肠炎是必要的组织学前提。黏膜显著嗜酸性粒细胞浸润与基底浆细胞增多相结合被认为是区分IBD型和非IBD型结肠炎的有用组织学特征。因此,本系统评价和荟萃分析旨在评估黏膜基底浆细胞增多和嗜酸性粒细胞增多在IBD型与非IBD型结肠炎组织学鉴别中的可靠性。我们检索了2000年1月1日至2022年7月30日期间的PROSPERO、PubMed、Embase和Scopus数据库,查找所有具有IBD和/或非IBD结肠炎病例组织学特征(包括黏膜基底浆细胞增多、嗜酸性粒细胞增多和中性粒细胞浸润)的研究类型(前瞻性、横断面或回顾性研究)。两名审阅者提取数据,并使用随机效应模型进行汇总。对59篇选定的文章进行了预先确定参数的评估。基底浆细胞增多和固有层浆细胞增多在IBD型和非IBD型结肠炎之间均未显示出任何显著相关性。IBD型结肠炎中基底浆细胞增多的比例及95%置信区间为0.50(0.19 - 0.82),非IBD型结肠炎中为0.46(0.40 - 0.52),P值为0.79。IBD中固有层浆细胞增多的比例及95%置信区间为0.67(0.42 - 0.92),非IBD型结肠炎中为0.60(0.35 - 0.85),P值为0.7。本系统评价记录了关于基底浆细胞增多和黏膜嗜酸性粒细胞增多等关键组织学特征的已发表数据匮乏,而这些特征被认为可区分IBD型和非IBD型结肠炎。

相似文献

1
A Systematic Review and Metaanalysis to Examine the Utility of Histological Parameters Such as Mucosal Basal Plasmacytosis and Eosinophilia for Distinguishing Inflammatory Bowel Disease and Non-IBD-Type Colitis.一项系统评价和荟萃分析,以检验诸如黏膜基底浆细胞增多症和嗜酸性粒细胞增多症等组织学参数在区分炎症性肠病和非炎症性肠病型结肠炎中的效用。
Int J Surg Pathol. 2025 May;33(3):516-527. doi: 10.1177/10668969241271352. Epub 2024 Sep 19.
2
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
3
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.粪便钙卫蛋白检测在鉴别炎症性和非炎症性肠病中的应用:系统评价和经济评估。
Health Technol Assess. 2013 Nov;17(55):xv-xix, 1-211. doi: 10.3310/hta17550.
4
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
7
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
8
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
9
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
10
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.